Related references
Note: Only part of the references are listed.Association of serum fibroblast growth factor 21 levels with skeletal muscle mass and mortality in chronic hemodialysis patients
Liang-Te Chiu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)
Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort Study
Morgan E. Grams et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Serum Levels of FGF21, β-Klotho, and BDNF in Stable Coronary Artery Disease Patients With Depressive Symptoms: A Cross-Sectional Single-Center Study
Yeshun Wu et al.
FRONTIERS IN PSYCHIATRY (2021)
Fibroblast growth factor 21 and protein energy wasting in hemodialysis patients
Adrian Post et al.
CLINICAL NUTRITION (2021)
Fibroblast Growth Factor 21 Predicts and Promotes Vascular Calcification in Haemodialysis Patients
Liqiong Jiang et al.
KIDNEY DISEASES (2021)
FGF21 and Chronic Kidney Disease
Joao Victor Salgado et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
FGF21 prevents low-protein diet-induced renal inflammation in aged mice
Han Fang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)
Does an increase in serum FGF21 level predict 28-day mortality of critical patients with sepsis and ARDS?
Xing Li et al.
RESPIRATORY RESEARCH (2021)
Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients
Shogo Yamamoto et al.
INTERNAL MEDICINE (2020)
Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease
Bradley Tucker et al.
ATHEROSCLEROSIS (2020)
Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification
Feng Gan et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Association of fibroblast growth factor 21 plasma levels with neonatal sepsis: preliminary results
Tania Siahanidou et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Fibroblast growth factor 21 in chronic kidney disease
Sahapab Anuwatmatee et al.
CLINICA CHIMICA ACTA (2019)
Fibroblast growth factor 21 deficiency aggravates obesity-induced hypothalamic inflammation and impairs thermogenic response
Luthfiyyah Mutsnaini et al.
INFLAMMATION RESEARCH (2019)
Predictive value of combined serum FGF21 and free T3 for survival in septic patients
Xing Li et al.
CLINICA CHIMICA ACTA (2019)
Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis
Kwok Leung Ong et al.
ATHEROSCLEROSIS (2019)
Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review
Daniel Yuan et al.
CLINICAL ENDOCRINOLOGY (2019)
Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials
Fahim Ebrahimi et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)
Kwok Leung Ong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Fibroblast Growth Factor 21 Attenuates Vascular Calcification by Alleviating Endoplasmic Reticulum Stress Mediated Apoptosis in Rats
Yuchen Shi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Serum FGF21 Is Associated with Future Cardiovascular Events in Patients with Coronary Artery Disease
Yun Shen et al.
CARDIOLOGY (2018)
Early increases in serum FGF21 levels predict mortality of septic patients
Xing Li et al.
CYTOKINE (2018)
Current and potential treatment options for hyperphosphatemia
Fabio Carfagna et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart
Hong Yang et al.
CELL DEATH & DISEASE (2018)
Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris
Jing Cheng et al.
BIOSCIENCE REPORTS (2018)
Fibroblast growth factor 21 attenuates calcification of vascular smooth muscle cells in vitro
Fangying Cao et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2017)
Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus
Chi Ho Lee et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
Marina Kohara et al.
PLOS ONE (2017)
Rush to the fire: FGF21 extinguishes metabolic stress, metaflammation and tissue damage
Yongde Luo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death
Yun Shen et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Fibroblast growth factor 21 - a key player in cardiovascular disorders?
Monika Lenart-Lipinska et al.
HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION (2017)
Understanding the Physiology of FGF21
Ffolliott Martin Fisher et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome
Junling Fu et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Fibroblast growth factor 21 (FGF21) inhibits macrophage -mediated inflammation by activating Nrf2 and suppressing the NF-κB signaling pathway
Yinhang Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease
Qing Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Endurance Exercise Reduces Hepatic Fat Content and Serum Fibroblast Growth Factor 21 Levels in Elderly Men
Hirokazu Taniguchi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications
Elena Gonzalez et al.
PLOS ONE (2016)
Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas
Garima Singhal et al.
PLOS ONE (2016)
Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes
Won Jin Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study
Kwok-Leung Ong et al.
DIABETOLOGIA (2015)
Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals
Lynae J. Hanks et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2015)
Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction
Janka Hindricks et al.
CLINICAL ENDOCRINOLOGY (2014)
Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation
Chi Zhang et al.
PLOS ONE (2013)
Serum Levels of the Adipokine FGF21 Depend on Renal Function
Sebastian Stein et al.
DIABETES CARE (2009)
Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study
Y. Slinin et al.
KIDNEY INTERNATIONAL (2006)
Share Paper
